TESE DE MESTRADO.pdf - Ubi Thesis

21 - Galarraga B, Khan F, Kumar P, Pullar T, Belch JJ. C-reactive protein: the underlying cause
of microvascular dysfunction in rheumatoid arthritis. Rheumatology 2008 Oct;47:1780-4.
22 - Ates A, Kinikli G, Turgay M, Akay G, Tokgoz G. Effects of rheumatoid factor isotypes on
disease activity and severity in patients with rheumatoid arthritis: a comparative study. Clin
Rheumatol 2006 Jun;26:538-45.
23 - Gonzalez A, Icen M, Kremers H, Crowson C, Davis JM, Therneau TM. Mortality Trends in
Rhematoid Arthritis: The Role of Rheumatoid Factor. J Rheumatol 2008 Jun;35(6):1009-14.
24 - Serdaroglu M, Çakirbay H, Deger O, Cengiz S, Kul S. The association of anti-CCP
antibodies with disease activity in rheumatoid arthritis. Rheumatol Int 2008 Apr;28:965-70.
25 - Im CH, Kang EH, Ryu HJ, Lee JH, Lee EY, Lee YJ et al. Anti-cyclic citrullinated peptide
antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared
epitope status. Rheumatol Int 2009 Aug;29:251-6.
26 - Papadopoulos NG, Tsiaousis GZ, Pavlitou-Tsiontsi A, Giannakou A, Galanopoulou VK.
Does the Presence of Anti-CCP Autoantibodies and Their Serum Levels Influence the Severity
and Activity in Rheumatoid Arthritis Patients? Clinic Rev Allerg Immunol 2007 Sep;34:11-5.
27 - Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the
disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology
2004;43:1252-5.
28 - Silva AF, Matos AN, Lima AM, Lima EF, Correa MI, Carvalho EM. Associação do
Anticorpo Anticitrulina e Gravidade da Artrite Reumatóide. Ver Bras Reumatol
2006;46(3):165-73.
29 - Inanc N, Dalkilic E, Kamah S, Kasapoglu-Gunal E, Elbir Y, Direskeneli H et al. Anti-CCP
antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 2006 Mar;26:17-23.
30 - Ates A, Karaaslan Y, Aksaray S. Predictive value of antibodies to cyclic citrullinated eptide
in patients with early arthritis. Clin Rheumatol 2007;26:499-504.
39